DRUG · Mapped RxNorm record
Nivolumab
Normalized identity: nivolumabView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer
NCT02481830
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Topotecan
Normalized identity: topotecanView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Amrubicin
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEffectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Lung Cancerverified · MONDO: lung cancer
Interventions
NivolumabDRUG · verified · RxNorm: nivolumab
TopotecanDRUG · verified · RxNorm: topotecan
AmrubicinDRUG
Sponsors & collaborators
Bristol-Myers Squibblead sponsor
Ono Pharmaceutical Co., Ltd.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02481830 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.